NewsPronto

 
Men's Weekly

.

PR Newswire

Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001

  • Written by PR Newswire Asia - News Pronto RSS
image

Highlights:

  • Neurizon® Therapeutics and Elanco Animal Health enter into an exclusive global licensing agreement
  • Provides worldwide rights for Neurizon to utilise Elanco's intellectual property, providing exclusive access to an extensive package of non-clinical studies and manufacturing data and outlines key terms for a future...

Read more: Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001